US ready to deliver millions of Covid vaccines to youngest children

    • The Food and Drug Administration (FDA) will convene a panel of experts on Jun 15 to weigh recommending the Pfizer vaccine for children aged 6 months through 4 years given in 3 doses, and Moderna's vaccine for those aged 6 months through 5 years given in 2 shots.
    • The Food and Drug Administration (FDA) will convene a panel of experts on Jun 15 to weigh recommending the Pfizer vaccine for children aged 6 months through 4 years given in 3 doses, and Moderna's vaccine for those aged 6 months through 5 years given in 2 shots. PHOTO: REUTERS
    Published Thu, Jun 9, 2022 · 10:30 PM

    THE White House on Thursday (Jun 9) said it had an operational plan to deliver 10 million doses of Covid vaccine for the nation's youngest children by Jun 20, pending clearance by regulators.

    The Food and Drug Administration (FDA) will convene a panel of experts on Jun 15 to weigh recommending the Pfizer vaccine for children aged 6 months through 4 years given in 3 doses, and Moderna's vaccine for those aged 6 months through 5 years given in 2 shots.

    Both appear safe and effective, according to results announced by the companies, though the FDA's independent analysis of the data should be posted in a few days' time.

    Children under 5 are the only age group not yet eligible for immunisation against Covid in most countries, a source of concern for many parents. FDA authorisation is widely considered the global gold standard.

    Severe disease from Covid is very rare among under-fives but can occur, with 482 US deaths in this age group since the start of the pandemic, or about 0.1 per cent of all deaths, according to official data.

    Children can also contract a rare post-viral condition called multisystem inflammatory syndrome in children (MIS-C), which has affected some 8,525 US children and killed 69.

    Like adults, some children who get Covid may go on to develop long Covid, with new, ongoing or returning symptoms, including brain fog and fatigue. AFP

    Share with us your feedback on BT's products and services